AbbVie today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging bispecific antibody, and lenalidomide, compared to rituximab ...
The Environment and Sustainable Development 5 Minute Fix is your quick update on key ESD developments across Australia. This edition covers new Commonwealth exposure draft National Environmental ...
All the new Nintendo Switch 2 games heading our way in 2026, from Star Fox to The Duskbloods ...
Fast Lane Only on MSN
The forgotten Ford V8 that punched above its weight
The story of Ford performance usually skips straight from the flathead era to the modern Coyote V8s, leaving a whole ...
Fibrosan, Inc., a U.S.-based affiliate of Fibrosan Glass and Reinforced Polyester of Turkiye’s Yucel Group, will build a new ...
President Donald Trump celebrated the Supreme Court ruling in the Slaughter case, which now allows the president to fire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results